Anika Therapeutics | ANIK - Vermögenswerte





Vermögenswerte Veränderung Datum
Abbott USD 86.71B 2.53B 2025-12
Agenus USD 226.8M 7.09M 2025-12
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Anika Therapeutics USD 190.27M 833K 2025-12
Arrowhead Research USD 1.6B 218.89M 2025-12
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Insmed USD 2.26B 96.18M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
J&J USD 199.21B 6.39B 2025-12
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Merit Medical Systems USD 2.69B 54.92M 2025-12
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 126.81B 2.99B 2025-12
Smith & Nephew USD 10.69B 150M 2025-12
Stryker USD 47.84B 787M 2025-12
Surmodics USD 178.56M 1.15M 2024-09
Veracyte USD 1.41B 38.23M 2025-12
Xencor USD 875.5M 6.68M 2025-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12